These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. Papayianni A; Serhan CN; Brady HR J Immunol; 1996 Mar; 156(6):2264-72. PubMed ID: 8690917 [TBL] [Abstract][Full Text] [Related]
3. Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side. Serhan CN Arch Immunol Ther Exp (Warsz); 2001; 49(3):177-88. PubMed ID: 11478391 [TBL] [Abstract][Full Text] [Related]
4. Lipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritis. O'Meara YM; Brady HR Kidney Int Suppl; 1997 Mar; 58():S56-61. PubMed ID: 9067945 [TBL] [Abstract][Full Text] [Related]
5. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Serhan CN Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201 [TBL] [Abstract][Full Text] [Related]
6. Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics. Serhan CN; Chiang N Rheum Dis Clin North Am; 2004 Feb; 30(1):69-95. PubMed ID: 15061569 [TBL] [Abstract][Full Text] [Related]
7. Potential vascular roles for lipoxins in the "stop programs" of host defense and inflammation. Brady HR; Papayianni A; Serhan CN Trends Cardiovasc Med; 1995; 5(5):186-92. PubMed ID: 21232258 [TBL] [Abstract][Full Text] [Related]
8. Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction. Filep JG; Khreiss T; József L Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):257-62. PubMed ID: 15979865 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of Disease: leukotrienes and lipoxins in scleroderma lung disease--insights and potential therapeutic implications. Kowal-Bielecka O; Kowal K; Distler O; Gay S Nat Clin Pract Rheumatol; 2007 Jan; 3(1):43-51. PubMed ID: 17203008 [TBL] [Abstract][Full Text] [Related]
14. Novel omega -- 3-derived local mediators in anti-inflammation and resolution. Serhan CN Pharmacol Ther; 2005 Jan; 105(1):7-21. PubMed ID: 15626453 [TBL] [Abstract][Full Text] [Related]
15. New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases. Yacoubian S; Serhan CN Nat Clin Pract Rheumatol; 2007 Oct; 3(10):570-9; quiz 1 p following 589. PubMed ID: 17906612 [TBL] [Abstract][Full Text] [Related]
16. Anti-microinflammatory lipid signals generated from dietary N-3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and N-3 PUFA therapeutic actions. Serhan CN; Clish CB; Brannon J; Colgan SP; Gronert K; Chiang N J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):643-54. PubMed ID: 11192938 [TBL] [Abstract][Full Text] [Related]
17. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. Serhan CN Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():433-55. PubMed ID: 12432935 [TBL] [Abstract][Full Text] [Related]
18. [Lipoxins--new view on old mediators carrying potent anti-inflammatory action]. Jarmakowska K; Kuna P Pol Merkur Lekarski; 2005 May; 18(107):491-5. PubMed ID: 16161940 [TBL] [Abstract][Full Text] [Related]
19. Eicosanoids in asthma. Wan KS; Wu WF Acta Paediatr Taiwan; 2007; 48(6):299-304. PubMed ID: 18437962 [TBL] [Abstract][Full Text] [Related]
20. Lipoxins in chronic inflammation. Kantarci A; Van Dyke TE Crit Rev Oral Biol Med; 2003; 14(1):4-12. PubMed ID: 12764016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]